The Journal of Urology
Volume 179, Issue 2 , Pages 439-444 , February 2008

The Distribution of Histological Subtypes of Renal Tumors by Decade of Life Using the 2004 WHO Classification

  • Ted A. Skolarus

      Affiliations

    • Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Nothing to disclose.
    • ,
  • Maria F. Serrano

      Affiliations

    • Department of Pathology, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Nothing to disclose.
    • ,
  • David A. Berger

      Affiliations

    • Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Nothing to disclose.
    • ,
  • Travis L. Bullock

      Affiliations

    • Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Financial interest and/or other relationship with American Medical Systems, Coloplast and Boston Scientific.
    • ,
  • Yan Yan

      Affiliations

    • Cancer Prevention and Control Program (Outreach Core), Siteman Cancer Center, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Nothing to disclose.
    • ,
  • Peter A. Humphrey

      Affiliations

    • Department of Pathology, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Financial interest and/or other relationship with ASCP Press and Lippincott Williams & Wilkins.
    • ,
  • Adam S. Kibel

      Affiliations

    • Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Corresponding Author InformationCorrespondence: Division of Urologic Surgery, Washington University in St. Louis, 4960 Children’s Place, Box 8242, St. Louis, Missouri 63110 (telephone: 314-362-8295).
    • Financial interest and/or other relationship with Sanofi-Aventis, Envisioneering Medical Systems, Ortho-McNeil and Wilex.

Received 15 June 2007

References 

  1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43
  2. Eble JN, Sauter G, Epstein JI, Sesterhenn IA. In: World Health Organization Classification of Tumours (Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs). vol 6:Lyon: IARC Press; 2004;p. 10–87chapt 1
  3. Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, et al. Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer. 1997;80:987
  4. Amin MB, Amin MB, Tamboli P, Javidan J, Stricker H, de-Peralta Venturina M, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol. 2002;26:281
  5. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol. 2003;27:612
  6. Moch H, Gasser T, Amin MB, Torhorst J, Sauter G, Mihatsch MJ. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer. 2000;89:604
  7. Patard JJ, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman A, et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol. 2005;23:2763
  8. Ficarra V, Artibani W. Staging system of renal cell carcinoma: current issues. Eur Urol. 2006;49:223
  9. Zisman A, Pantuck AJ, Dorey F, Said JW, Shvarts O, Quintana D, et al. Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol. 2001;19:1649
  10. Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z. 2004 WHO classification of the renal tumors of the adults. Eur Urol. 2006;49:798
  11. Gillett MD, Cheville JC, Karnes RJ, Lohse CM, Kwon ED, Leibovich BC, et al. Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses. J Urol. 2005;173:1893
  12. Verhoest G, Veillard D, Guille F, De La Taille A, Salomon L, Abbou CC, et al. Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma. Eur Urol. 2007;51:1298
  13. AbouElFettouh HI, Cherullo EE, El-Jack M, AlMaslamani Y, Novick AC. Sporadic renal cell carcinoma in young adults: presentation, treatment, and outcome. Urology. 2002;60:806
  14. Sanchez-Ortiz RF, Rosser CJ, Madsen LT, Swanson DA, Wood CG. Young age is an independent prognostic factor for survival of sporadic renal cell carcinoma. J Urol. 2004;171:2160
  15. Chow WH, Devesa SS, Warren JL, Fraumeni JF. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281:1628
  16. Eggener SE, Rubenstein JN, Smith ND, Nadler RB, Kontak J, Flanigan RC, et al. Renal tumors in young adults. J Urol. 2004;171:106
  17. Patard JJ, Rodriguez A, Rioux-Leclercq N, Guille F, Lobel B. Prognostic significance of the mode of detection in renal tumours. BJU Int. 2002;90:358
  18. Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology. 1998;51:203

 Study received institutional board approval.Editor’s Note: This article is the first of 5 published in this issue for which category 1 CME credits can be earned. Instructions for obtaining credits are given with the questions on pages 794 and 795.

PII: S0022-5347(07)02578-5

doi: 10.1016/j.juro.2007.09.076

The Journal of Urology
Volume 179, Issue 2 , Pages 439-444 , February 2008

Article Tools